glp-1 receptor agonist type 1 diabetes trial liraglutide Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Indications for GLP-1/GIP RA Summary
Description
Polonsky, PhD, CDCES & Susan Guzman, PhD (Behavioral Diabetes Institute) that reveals psychosocial forces behind diabetes self-management tools to break through resistance and inspire change
10.1093/brain/aws059 [DOI] [PubMed] [Google Scholar] Zhang R
doi: 10.1007/s13300-019-00735-7
271: R848R856 [DOI] [PubMed] [Google Scholar] 153.Turton MD, OShea D, Gunn I, et al
Additionally, vascular endothelium becomes less effective at regulating blood flow and preventing clot formation, leading to endothelial dysfunction, increasing the risk of atherosclerosis, thrombosis, and other vascular diseases
The point is not to be anti-medication
